Research output

The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • TUMOR RESPONSE, OPEN-LABEL, PHARMACOKINETICS, TOLERANCE, SURVIVAL, EFFICACY, SAFETY
View graph of relations

Details

Original languageEnglish
Pages (from-to)363-370
Number of pages8
JournalTargeted Oncology
Volume13
Issue number3
DOIs
Publication statusPublished - Jun 2018